MedCalcHub stores your favorites, history, and saved calculations locally in your browser using localStorage. This data never leaves your device.
Optional advertising, when enabled, may use third-party cookies or similar technologies. You can accept or reject advertising below.
Estimates pancreatic beta-cell function from fasting plasma glucose and fasting serum insulin using the HOMA equation.
Clinical decision-support tool for qualified healthcare professionals. Results are not a diagnosis and should not replace professional clinical judgment.
HOMA-B estimates pancreatic beta-cell function from fasting glucose and insulin. It models the expected insulin output for a given fasting glucose: for any glucose level, a higher fasting insulin implies greater beta-cell responsiveness, expressed here as (20 × insulin) / (glucose − 3.5) with glucose in mmol/L and insulin in µU/mL. The result is reported in percent units. The value is an indirect, fasting-based estimate of secretion, not a direct measurement of beta-cell mass or of the dynamic insulin response to a meal or glucose load. Because the index is computed relative to the prevailing fasting glucose, interpretation depends on the glucose level itself as well as on assay calibration and the fasting state. HOMA-B is not reliable in type 1 diabetes, in patients on exogenous insulin, or in acute illness, and it has limited comparability across populations and disease states. It should not be used as a standalone measure of beta-cell reserve; it is best paired with HOMA-IR and clinical evaluation to separate beta-cell dysfunction from insulin resistance.
Specialty
EndocrinologyCategory
EndocrinologyDifficulty
Basic
Estimated Time
30 seconds
Version
1.0
Last Updated
2026-08-06
Formula
Keywords
Normal Range
100–200%
| Classification | Range |
|---|---|
Severe beta-cell dysfunction | <50.1 |
Reduced beta-cell function | 50–100 |
Normal beta-cell function | 100–200 |
Hyperinsulinemia | ≥200 |
Estimates pancreatic beta-cell function relative to the prevailing fasting glucose, complementing HOMA-IR in the assessment of glucose–insulin homeostasis.
HOMA-B = (20 x fasting insulin) / (fasting glucose (mmol/L) - 3.5), an estimate of pancreatic beta-cell function.
Fasting plasma glucose in mmol/L, reduced by 3.5 in the denominator.
Fasting serum insulin in microU/mL, multiplied by 20 in the numerator.
HOMA-B of 100–200% is generally considered normal beta-cell function; 50–100% suggests reduced function; < 50% suggests significant beta-cell dysfunction; and ≥ 200% reflects hyperinsulinemia. Values must be interpreted in the context of the patient's fasting glucose and insulin.
HOMA-B provides a practical estimate of beta-cell function from routine fasting labs and helps track the progressive beta-cell decline characteristic of type 2 diabetes.
A 50-year-old man with type 2 diabetes has a fasting glucose of 6.0 mmol/L and fasting insulin of 10 µU/mL.
Inputs:
Expected Result: HOMA-B = (20 × 10) / (6.0 − 3.5) = 80%, suggesting reduced beta-cell function (50–100% range).
A HOMA-B below 100% suggests reduced beta-cell function, meaning the pancreas is producing less insulin than expected for the glucose level. This is common in progressive type 2 diabetes.
HOMA-B estimates how well the pancreas produces insulin (beta-cell function), while HOMA-IR estimates how well the body responds to it (insulin resistance).
A normal HOMA-B is approximately 100–200%. Values below 50% indicate significant beta-cell dysfunction.
Disclaimer: This calculator is intended for educational and research purposes only. HOMA-B is an estimate of beta-cell function and must not be used as a standalone diagnostic test.
Estimating beta-cell function from fasting labs.
Not validated in type 1 diabetes or on exogenous insulin.
Estimating insulin resistance.
Measures resistance, not secretion.
Quick sensitivity estimate.
Inverse of HOMA-IR; does not assess beta cells.